Sven Arne Andréasson
Direttore/Membro del Consiglio presso MENDUS AB
Patrimonio netto: - $ in data 31/05/2024
Provenienza dei contatti di primo grado di Sven Arne Andréasson
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 39 | |
25
| Public Company | Biotechnology | 25 |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.
24
| Extinct | Pharmaceuticals: Major | 24 |
Pharmacia AB
20
| Extinct | Pharmaceuticals: Major | 20 |
| Holding Company | Medical Specialties | 9 | |
| Public Company | Biotechnology | 8 | |
Cellastra, Inc.
 Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation.
5
| Private Company | Biotechnology | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Sven Arne Andréasson tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Uppsala | College/University | Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| University of Lund | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Director/Board Member Chairman | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor Sales & Marketing Corporate Officer/Principal | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member President Chief Executive Officer Director of Finance/CFO | |
DCPrime BV
 DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer Chairman Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| University of Lyon | College/University | Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Director/Board Member Chief Investment Officer | |
| IOMAI CORPORATION | Biotechnology | Chief Executive Officer Founder Chief Operating Officer | |
Learning Undefeated, Inc.
 Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Learning Undefeated, Inc. is a non-profit organization that provides STEM education opportunities for underserved communities. The non-profit company is based in Gaithersburg. The American company's flagship education program features mobile STEM labs that have provided hands-on learning opportunities to more than 200,000 K-12 students in 18 states since 2003. The company also operates several other celebrated STEM education programs including the Young Science Explorers program, a summer camp for middle school students, and the Advancing Tomorrow's Leaders in STEM (ATLAS) college and career exploration program. Learning Undefeated is driving race and gender equity in STEM through experiential and deep-impact learning experiences for students from under-resourced communities. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Chairman | |
| Université Catholique de Louvain | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree | |
| TESARO INC | Pharmaceuticals: Major | Founder Chairman Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| Dartmouth College | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
| RECIPHARM AB (PUBL) | Biotechnology | Director/Board Member Founder Founder | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| University of Leiden | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| BIOARCTIC AB | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Human Resources Officer | |
| Stockholm School of Economics | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Chairman Founder | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| OSIRIS THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer Chief Operating Officer | |
The United States Pharmacopeia
 The United States Pharmacopeia Pharmaceuticals: MajorHealth Technology The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Doctorate Degree Undergraduate Degree | |
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Johns Hopkins Bloomberg School of Public Health | College/University | Corporate Officer/Principal Graduate Degree | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Director/Board Member Corporate Officer/Principal | |
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Doctorate Degree Corporate Officer/Principal | |
NEURONAX SA
 NEURONAX SA Pharmaceuticals: MajorHealth Technology NEURONAX SA develops and provides drugs supporting neural repair to treat degenerative disorders of the central nervous system. Its services include cell culture, in vitro evaluation, neurotrophic and neuroprotective effects analysis, culture analyses, and stem cells. The company was founded by Stéphane Gobron, Fabrice Cailloux, and Pierre-Yves Simonin in 2003 and is headquartered in Saint-Beauzire, France. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer | |
| XINTELA AB | Biotechnology | Director/Board Member Director/Board Member | |
| B&E Invest AB | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 24 |
| Svezia | 14 |
| Belgio | 6 |
| Paesi Bassi | 5 |
| Francia | 4 |
Settori
| Health Technology | 28 |
| Consumer Services | 16 |
| Commercial Services | 5 |
| Finance | 3 |
| Miscellaneous | 2 |
Posizioni
| Director/Board Member | 551 |
| Corporate Officer/Principal | 252 |
| Chairman | 200 |
| Independent Dir/Board Member | 149 |
| Chief Executive Officer | 115 |
Contatti più connessi
| Insiders | |
|---|---|
| Peter James Arthur Benson | 58 |
| Gunnar Magnus Modee Persson | 51 |
| Rolf Classon | 47 |
| David Mott | 45 |
| Göran Albert Ando | 44 |
| Thomas Bengt Eldered | 41 |
| Wenche Nelly A. Rolfsen Sandsborg | 36 |
| Peter Sjöstrand | 35 |
| Rajiv Indravadan Modi | 31 |
| Claes Tomas Post | 30 |
| Gail Boudreaux | 30 |
| Luc Dochez | 26 |
| Dharminder Singh Chahal | 25 |
| Marc Beer | 25 |
| Gary Evans | 25 |
- Borsa valori
- Insiders
- Sven Arne Andréasson
- Connessioni Società
